Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing.
作者信息
Banzi Rita, Moja Lorenzo, Moschetti Ivan, Liberati Alessandro, Gensini Gian Franco, Gusinu Roberto, Conti Andrea A
机构信息
Italian Cochrane Centre, Mario Negri Institute for Pharmacological Research, Via Eritrea 62, 20157 Milan, Italy.
出版信息
Intern Emerg Med. 2008 Mar;3(1):53-6. doi: 10.1007/s11739-008-0139-x. Epub 2008 Mar 4.
PMID:18317866
Abstract
摘要
Zotero 插件